Navigation Links
NPC Conference to Address Questions on Ability to Share Health Research Findings
Date:2/6/2012

WASHINGTON, Feb. 6, 2012 /PRNewswire-USNewswire/ -- To examine key issues around asymmetries, or inequalities, in communicating health information coming from the growing body of comparative effectiveness research (CER), the National Pharmaceutical Council, the National Health Council and WellPoint are sponsoring a conference, Asymmetry in the Ability to Communicate CER Findings: Ethics and Issues for Informed Decision Making. 

With billions of dollars in funding being invested in comparative effectiveness research, patients, providers, payers and other health care decision-makers will have more information than ever before about the safety and effectiveness of treatment options. However, not all stakeholders have equal ability to share information in the current regulatory environment. The conference will facilitate discussion about the information needs of patients, payers and other stakeholders, and how the First Amendment and other legal issues apply. Presenters will share with attendees a proposed ethical framework for communicating CER information.

Who: Confirmed speakers include:

  • Arthur Caplan, PhD, Director, Center for Bioethics, University of Pennsylvania
  • Susan Dentzer, Editor-in-Chief, Health Affairs/Project HOPE
  • Robert W. Dubois, MD, PhD, Chief Science Officer, National Pharmaceutical Council
  • Scott Gottlieb, MD, Resident Fellow, American Enterprise Institute
  • Stephen Hume, PsyD, Alzheimer's patient representative, and his care partner, Candace Darcy
  • Aaron S. Kesselheim, MD, JD, MPH, Assistant Professor of Medicine, Harvard Medical School
    Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital
  • Joshua D. Lenchus, DO, RPh, FACP, Associate Director, University of Miami-Jackson Memorial Hospital Center for Patient Safety, and Associate Professor of Medicine, University of Miami Miller School of Medicine
  • Gerald F. Masoudi, Partner, Covington & Burling LLP
  • Steven J. Romano, MD, Senior Vice President, Head, Medicines Development Group, Primary Care Business, Pfizer Inc
  • Robert J. Temple, MD, Deputy Center Director for Clinical Science, U.S. Food and Drug Administration's (FDA's) Center for Drug Evaluation and Research, and Acting Deputy Director of the FDA's Office of Drug Evaluation I
  • Tevi Troy, PhD, Senior Fellow, Hudson Institute, and former Deputy Secretary, U.S. Department of Health and Human Services
  • Marcus Wilson, PharmD, President, HealthCore

When: Thursday, February 9, 2012, from 9:30 a.m. to 4:30 p.m.  The conference will open at 8:30 a.m. for registration and a continental breakfast.

Where:  Omni Shoreham Hotel, 2500 Calvert St. NW, Washington, D.C.  

Registration is complimentary at http://www.npcnow.org/asym12.     

To join the conversation on Twitter, use the hashtag #asym12.


'/>"/>
SOURCE National Pharmaceutical Council
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Webcast Alert: Heska Announces Fourth Quarter and Year-End 2011 Earnings Conference Call Webcast
2. Stryker Presents Results of the TREVO Prospective Clinical Study at the International Stroke Conference
3. American Pacific to Release Financial Results and Hold Fiscal 2012 First Quarter Investor Teleconference
4. CryoLife Announces Release Date and Teleconference Call Details for 2011 Fourth Quarter and Year End Financial Results
5. Winner Medical Group Inc. to Host First Quarter 2012 Earnings Conference Call on Thursday, February 9, 2012 at 08:00 p.m. EST
6. Vision-Sciences, Inc. to Webcast, Live, at RetailInvestorConferences.com on February 2nd
7. ThermoGenesis Provides Update on Res-Q® Clinical Evaluations at Leading Stem Cell Therapy Conference
8. Hill-Rom to Participate in the Leerink Swann 2012 Global Healthcare Conference
9. Auxilium Pharmaceuticals to Present at the Leerink Swann 2012 Global Healthcare Conference
10. Regeneron to Report Full Year 2011 Financial and Operating Results and Host Conference Call and Webcast on February 16, 2012
11. Palomar Medical Technologies to Host Fourth Quarter and Year End 2011 Financial Results Conference Call and Webcast on February 9, 2012 at 11:30 AM Eastern Time
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... 24, 2016 Dehaier Medical Systems Ltd. (NASDAQ: ... develops, markets and sells medical devices and wearable sleep ... a strategic cooperation agreement with Hongyuan Supply Chain Management ... on June 20, 2016, to develop Dehaier,s new Internet ... agreement, Dehaier will leverage Hongyuan Supply Chain,s sales platform ...
(Date:6/24/2016)... , June 24, 2016 ... appointment of Dr. Edward Futcher to ... Director, effective June 23, 2016.Dr. Futcher was also ... and Governance Committees.  As a non-executive member of ... expertise and strategic counsel to VolitionRx in connection ...
(Date:6/23/2016)... 23, 2016 Research and Markets ... Market by Type (Organic Chemical (Sugar, Petrochemical, Glycerin), Inorganic ... Coating, Parenteral) - Global Forecast to 2021" report ... The global pharmaceutical excipients market is projected to ... of 6.1% in the forecast period 2016 to 2021. ...
Breaking Medicine Technology:
(Date:6/26/2016)... ... June 26, 2016 , ... PawPaws brand pet ... product that was developed to enhance the health of felines. The formula is all-natural ... two main herbs in the PawPaws Cat Kidney Support Supplement Soft Chews ...
(Date:6/25/2016)... ... June 25, 2016 , ... ... and applications at AcademyHealth’s Annual Research Meeting June 26-28, 2016, at the Hynes ... important health care topics including advance care planning, healthcare costs and patient and ...
(Date:6/25/2016)... ... June 25, 2016 , ... "With 30 hand-drawn hand gesture ... said Christina Austin - CEO of Pixel Film Studios. , ProHand Cartoon’s package ... Final Cut Pro X . Simply select a ProHand generator and drag it ...
(Date:6/25/2016)... ... 25, 2016 , ... Dr. Calvin Johnson has dedicated his ... implemented orthobiologic procedures as a method for treating his patients. The procedure is ... to perform the treatment. Orthobiologics are substances that orthopaedic surgeons use to help ...
(Date:6/24/2016)... ... 2016 , ... A recent article published June 14 on E ... goes on to state that individuals are now more comfortable seeking to undergo not ... as calf and cheek reduction. The Los Angeles area medical group, Beverly Hills Physicians ...
Breaking Medicine News(10 mins):